Unless otherwise specifically indicated, the content of this communication is for information purpose only and should not be regarded as an offer to sell or a solicitation of an offer to buy securities, futures, options, loans, investment products, or other financial products or services, an official conformation of any transaction, or an official account statement of Cowen and …

Jan 4, 2024 · The TD Cowen Insight Our 9th Annual U.S. Municipal Spending Survey tracks opex and capex outlooks at ~50 municipalities across the U.S. with a focus on larger cities to ensure adequate population and spending coverage.

At Cowen, we are proud of our historical innovation and expertise in commission management. We are recognized as a leader in the industry—a cutting-edge partner that brings respected insights and a depth of knowledge and customized services to our clients.

Sep 26, 2023 · TD Cowen Research shares an updated outlook for the renewabale diesel & sustainable aviation fuel markets. Learn more in their latest TD has acquired Cowen Inc.

Jul 5, 2023 · My name is Oliver Chen, Cowen’s new Platform Retail and Luxury Analyst. In this episode, we’re excited to explore Levi’s impressive apparel transformation in leadership and experiential omnichannel capabilities.

Jun 7, 2022 · Cowen research analyst release their 10th Annual report probing the growth of Public Cloud and how industries are bracing for deployment & adoption.

Apr 9, 2018 · For more information, contact your Cowen sales representative. Related Topics Online Travel & Hotels Research Technology, Media & Telecom

Dec 5, 2023 · TD Cowen issued its first report on liquid biopsy ten years ago. In it, we introduced the concept, highlighted the early entrants, and evaluated the opportunity. Today, commercial traction (in particular for oncology) is material with a handful of players (mostly public) dominating.

Jan 29, 2024 · Get to Know TD Cowen. Transactions. $250 Million. Vera Therapeutics, Inc. Follow-on Offering. Bookrunner, January 2024. Vera Therapeutics, Inc (“Vera” or the “Company”) is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases. Vera’s ...

Aug 29, 2023 · TD Cowen analyst Marc Bianchi offers an overview of how public and private companies supply nuclear power, regional dynamics, and why nuclear growth is needed for decarbonization.